Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
85-98
Author(s):
Vicente Andrés and Claudia Castro
Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
77-93
Author(s):
C. Cal, H. Garban, A. Jazirehi, C. Yeh, Y. Mizutani and B. Bonavida
Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
95-117
Author(s):
S. Shinkaruk, M. Bayle, G. Lain and G. Deleris
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
133-138
Author(s):
Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia
Glucuronides in Anti-Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
139-150
Author(s):
Xi Chen, Bingyuan Wu and Peng George Wang
Cardiac Toxicity of Antineoplastic Anthracyclines
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
151-171
Author(s):
Riccardo Zucchi and Romano Danesi
Strategy of Computer-Aided Drug Design
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
33-40
Author(s):
A. V. Veselovsky and A. S. Ivanov
Unfolding the Pathophysiological Role of Bioactive Lysophospholipids
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
3
Page:
23-32
Author(s):
Yan Xu, Yi-jin Xiao, Kui Zhu, Linnea M. Baudhuin, Jun Lu, Guiying Hong, Kwan-sik Kim, Kelly L. Cristina, Li Song and Freager S. Williams
Vitamin D Analogs- Drug Design Based on Proteins Involved in Vitamin D Signal Transduction
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
3
Page:
43-66
Author(s):
Sonoko Masuda and Glenville Jones